Skip to main content

Table 3 Risk of bias assessed by NOS assessment tool

From: Double-carbapenem therapy in the treatment of multidrug resistant Gram-negative bacterial infections: a systematic review and meta-analysis

Author/Year

Design

Selection

Comparability

Outcome

/Exposure

NOS

score

Pascale, 2017

case-control study

⁕⁕⁕

⁕⁕

⁕⁕

7

Venugopalan, 2017

cohort study

⁕⁕⁕⁕

⁕⁕

7

Cancelli, 2018

cohort study

⁕⁕⁕⁕

⁕⁕

7